Rare Diseases
Article
NORD Provides Update on Tax Cuts and Jobs Act
Article
NORD Launches Year-Long 35th Anniversary Observance
Article
Visit NORD’s Website to Learn About Current or Future Research Funding Opportunities
Article
NORD Awards Five Research Grants
Article
January 12 Is Deadline for Rare Impact Awards Nominations
Article
Join 7,000 Miles Campaign to Support Programs for Rare Disease PatientsJoin 7,000 Miles Campaign to Support Programs for Rare Disease Patients
Article
Osteogenesis Imperfecta Foundation Biennial Conference
Article
National Niemann-Pick Disease Foundation Seeks Executive Director
Article
HCU Network America Grant Requests
Article
Cornelia de Lange Syndrome Foundation Call for Abstracts
News
FDA grants breakthrough therapy designation for severe aplastic anemia drug
Eltrombopag, from Novartis, will get expedited review for first-line treatment of severe aplastic anemia. It is already approved as a second-line...